Advertisement

Search Results

Advertisement

Your search for Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial matches 1 pages

Showing 1 - 1

Advertisement

By Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial / 2018 ASCO Annual Meeting

Bernard J. Escudier, MD, on RCC: Results From the IMmotion151 Trial

Bernard J. Escudier, MD, of Gustave Roussy, discusses patient-reported outcomes for atezolizumab plus bevacizumab vs sunitinib in treatment-naive metastatic renal cell carcinoma (Abstract 4511).

Advertisement

Advertisement

Nov

22

Today In Oncology

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

FDA Grants Accelerated Approval to Zanidatamab-hrii for Previously Treated Unresectable or Metastatic HER2-Positive Biliary Tract Cancer

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma

Advertisement

© 2024 HSP News Service, L.L.C.